X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6243) 6243
Publication (905) 905
Book Chapter (90) 90
Book Review (57) 57
Book / eBook (26) 26
Conference Proceeding (15) 15
Dissertation (9) 9
Web Resource (9) 9
Magazine Article (7) 7
Newsletter (7) 7
Reference (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
Newspaper Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4572) 4572
index medicus (3692) 3692
hematology (2933) 2933
female (1993) 1993
male (1990) 1990
myeloproliferative neoplasms (1942) 1942
mutation (1857) 1857
oncology (1843) 1843
middle aged (1585) 1585
polycythemia-vera (1550) 1550
essential thrombocythemia (1508) 1508
aged (1441) 1441
myeloproliferative disorders (1410) 1410
myeloproliferative disorders - genetics (1326) 1326
adult (1304) 1304
janus kinase 2 - genetics (1265) 1265
myelofibrosis (1098) 1098
leukemia (1044) 1044
animals (896) 896
aged, 80 and over (780) 780
jak2 (766) 766
genetic aspects (760) 760
tumors (706) 706
prognosis (633) 633
tyrosine kinase jak2 (633) 633
cancer (614) 614
hemic and lymphatic diseases (606) 606
myeloproliferative disorders - pathology (588) 588
polycythemia vera (583) 583
diagnosis (569) 569
primary myelofibrosis (561) 561
mice (557) 557
research (557) 557
myeloproliferative disorders - diagnosis (535) 535
myeloproliferative neoplasm (523) 523
risk factors (505) 505
acute myeloid-leukemia (500) 500
analysis (471) 471
care and treatment (464) 464
disorders (454) 454
myelodysplastic syndromes (448) 448
abridged index medicus (446) 446
adolescent (433) 433
young adult (422) 422
thrombosis (417) 417
pathology (416) 416
article (407) 407
neoplasms (401) 401
primary myelofibrosis - genetics (397) 397
myeloproliferative disorders - drug therapy (391) 391
thrombocythemia, essential - genetics (391) 391
gene mutations (389) 389
bone marrow (378) 378
mutations (376) 376
myeloid metaplasia (369) 369
health aspects (367) 367
hematology, oncology and palliative medicine (366) 366
treatment outcome (361) 361
cell biology (360) 360
medicine & public health (353) 353
signal transduction (347) 347
polycythemia vera - genetics (339) 339
janus kinase 2 (338) 338
ruxolitinib (338) 338
stem cells (335) 335
bone marrow - pathology (326) 326
janus kinase 2 - metabolism (318) 318
myeloproliferative disorders - complications (315) 315
janus kinase 2 - antagonists & inhibitors (312) 312
chronic myelomonocytic leukemia (304) 304
chronic myeloid-leukemia (298) 298
myeloproliferative disorders - metabolism (298) 298
retrospective studies (298) 298
classification (294) 294
survival (292) 292
disease (287) 287
international working group (286) 286
patients (285) 285
chronic myelogenous leukemia (274) 274
jak2 v617f mutation (270) 270
calreticulin - genetics (267) 267
antineoplastic agents - therapeutic use (264) 264
gene expression (264) 264
expression (263) 263
therapy (263) 263
child (262) 262
polycythemia (261) 261
protein kinase inhibitors - therapeutic use (258) 258
acute lymphoblastic-leukemia (255) 255
chronic myeloproliferative disorders (255) 255
disease progression (252) 252
medicine, general & internal (246) 246
medicine (242) 242
myelodysplastic syndrome (242) 242
development and progression (241) 241
dna mutational analysis (235) 235
kinases (234) 234
world-health-organization (231) 231
myelodysplastic syndromes - genetics (229) 229
transplantation (229) 229
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (14) 14
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Periodical Stacks (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5993) 5993
German (78) 78
French (66) 66
Chinese (61) 61
Japanese (59) 59
Russian (34) 34
Spanish (27) 27
Hungarian (15) 15
Polish (15) 15
Korean (10) 10
Czech (6) 6
Portuguese (6) 6
Turkish (5) 5
Italian (3) 3
Slovak (3) 3
Danish (2) 2
Croatian (1) 1
Hebrew (1) 1
Indonesian (1) 1
Norwegian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2168 - 2181
Journal Article
1999, Basic and clinical oncology, ISBN 9780824799014, Volume 16., xi, 442
Book
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. e609 - e620
Summary Neonatal cancer is rare and comprises a heterogeneous group of neoplasms with substantial histological diversity. Almost all types of paediatric cancer... 
Hematology, Oncology and Palliative Medicine | MESENCHYMAL TUMOR | TRANSIENT MYELOPROLIFERATIVE DISORDER | INTERNATIONAL-SOCIETY | ONCOLOGY | JUVENILE MYELOMONOCYTIC LEUKEMIA | 1ST YEAR | RISK | FETAL | PRENATAL-DIAGNOSIS | BRAIN-TUMORS | CHILDREN | Neoplasms - etiology | Retinoblastoma - therapy | Soft Tissue Neoplasms - diagnosis | Humans | Liver Neoplasms - therapy | Neoplasms - diagnosis | Neuroblastoma - therapy | Maternal Exposure | Neoplasms, Germ Cell and Embryonal - diagnosis | Kidney Neoplasms - diagnosis | Congenital Abnormalities - diagnosis | Neoplasms - complications | Neoplasms - therapy | Neoplasms - genetics | Delivery, Obstetric | Female | Retinoblastoma - diagnosis | Infant, Newborn | Kidney Neoplasms - therapy | Soft Tissue Neoplasms - therapy | Diagnosis, Differential | Genetic Predisposition to Disease | Prenatal Diagnosis | Leukemia - therapy | Central Nervous System Neoplasms - therapy | Neuroblastoma - diagnosis | Interdisciplinary Communication | Liver Neoplasms - diagnosis | Ultrasonography, Prenatal | Urogenital Neoplasms - therapy | Leukemia - diagnosis | Disease Management | Neoplasms - pathology | Central Nervous System Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - therapy | Urogenital Neoplasms - diagnosis | Infants (Newborn) | Genetic disorders | Sarcoma | Pregnant women | Leukemia | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 09/2013, Volume 122, Issue 13, pp. 2176 - 2184
Major causes of morbidity and mortality in myeloproliferative neoplasms are represented by arterial and venous complications, progression to myelofibrosis, and... 
Myeloproliferative Disorders - complications | Thrombosis - etiology | Humans | Risk Factors
Journal Article
by Nand, S
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 895 - 895
Journal Article
Blood, ISSN 0006-4971, 02/2017, Volume 129, Issue 6, pp. 704 - 714
Molecular diagnostics has generated substantial dividends in dissecting the genetic basis of myeloid neoplasms with eosinophilia. The family of diseases... 
GROWTH-FACTOR RECEPTOR | BCR-JAK2 FUSION GENE | MYELOPROLIFERATIVE NEOPLASM | TYROSINE KINASE | TERM-FOLLOW-UP | IDIOPATHIC HYPEREOSINOPHILIC SYNDROME | FIP1L1-PDGFRA FUSION | HEMATOLOGY | SYSTEMIC MASTOCYTOSIS | IMATINIB MESYLATE | PCM1-JAK2 FUSION | Eosinophilia - therapy | Oncogene Proteins, Fusion - metabolism | Leukemia - pathology | Proto-Oncogene Proteins c-abl - antagonists & inhibitors | Humans | Gene Expression Regulation, Neoplastic | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | fms-Like Tyrosine Kinase 3 | Antineoplastic Agents - therapeutic use | Myeloproliferative Disorders - pathology | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Receptor, Platelet-Derived Growth Factor beta - genetics | Myeloproliferative Disorders - genetics | Transplantation, Homologous | Eosinophilia - pathology | Hypereosinophilic Syndrome - diagnosis | Receptor, Platelet-Derived Growth Factor beta - antagonists & inhibitors | Receptor, Platelet-Derived Growth Factor alpha - antagonists & inhibitors | Janus Kinase 2 - metabolism | Eosinophilia - genetics | Hypereosinophilic Syndrome - pathology | Hypereosinophilic Syndrome - therapy | Eosinophilia - diagnosis | Janus Kinase 2 - antagonists & inhibitors | Leukemia - genetics | Receptor, Platelet-Derived Growth Factor beta - metabolism | Myeloproliferative Disorders - diagnosis | Proto-Oncogene Proteins c-abl - genetics | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Myeloproliferative Disorders - therapy | Janus Kinase 2 - genetics | Hematopoietic Stem Cell Transplantation | Leukemia - therapy | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Receptor, Platelet-Derived Growth Factor alpha - genetics | Leukemia - diagnosis | Proto-Oncogene Proteins c-abl - metabolism | Hypereosinophilic Syndrome - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 894 - 896
To the Editor: In his article on myeloproliferative neoplasms, Spivak (June 1 issue) 1 briefly addresses the diagnostic effect of morphologic features and... 
MEDICINE, GENERAL & INTERNAL | Myeloproliferative Disorders | Mutation | Humans | Neoplasms | Janus Kinase 2 - genetics
Journal Article
Blood, ISSN 0006-4971, 03/2016, Volume 127, Issue 10, pp. 1325 - 1335
Journal Article